Reliability of MRI and Ultrasound in Cervical Epidural Needle Depth Estimation
Launched by DAMLA YÜRÜK · Dec 18, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well magnetic resonance imaging (MRI) and ultrasound can help doctors determine how deep to insert a needle during cervical epidural injections, which are treatments for chronic neck pain and related issues. Currently, doctors often use a method called fluoroscopy, which involves radiation, and this study aims to find safer imaging options that still provide accurate results. The researchers want to see if using MRI or ultrasound can help reduce exposure to radiation while ensuring that the injections are done safely and effectively.
To participate in this study, you need to be at least 18 years old, have been diagnosed with chronic neck pain, and be referred for a cervical epidural steroid injection. You should also be able to understand and agree to participate in the study. However, individuals who are pregnant, have certain medical conditions, or have had specific surgeries may not be eligible. If you qualify and choose to participate, you can expect to undergo imaging tests and receive the injection while researchers monitor the process to gather important information about these imaging methods.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years, Diagnosed with chronic cervical pain, Referred for cervical epidural steroid injection, Patients capable of providing informed consent.
- Exclusion Criteria:
- • Age \< 18 years, Pregnancy or breastfeeding, History of coagulation disorders or use of anticoagulants, Severe systemic infections or local infections at the injection site, Known allergy to steroids or local anesthetics, Uncontrolled diabetes mellitus, Patients with spinal tumors or significant spinal deformities, Previous cervical spine surgery, Cognitive impairment preventing informed consent or follow-up participation.
About Damla Yürük
Damla Yürük is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a strong focus on ethical practices and regulatory compliance, Damla Yürük collaborates with healthcare professionals and institutions to design and implement rigorous clinical trials across various therapeutic areas. The organization emphasizes transparency, patient safety, and scientific integrity, ensuring that all trials contribute valuable insights to the medical community while prioritizing the well-being of participants. Through a strategic approach and a commitment to excellence, Damla Yürük aims to drive progress in the field of medicine and contribute to the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
DAMLA YÜRÜK, Associate Professor of Algolog
Principal Investigator
Ankara Etlik City Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported